Protagonist Therapeutics, Inc (PTGX) News

Latest headlines that mention PTGX, newest first · each headline opens the original publisher

PTGX quote

Last price: $128.75
Day change: -5.71%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

PTGX headlines

latest coverage

Seeking Alpha News 1mo ago

Protagonist Therapeutics, Inc. (PTGX) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

General T2PTGX

Seeking Alpha 1mo ago

Protagonist Therapeutics authorizes $300M share repurchase program

General T2PTGX

Investing.com 1mo ago

Protagonist Therapeutics authorizes $300 million buyback plan

General T3PTGX

Yahoo Finance 1mo ago

Protagonist (PTGX) Swings To A Profit As Two Drugs Near Blockbuster Status

General T2PTGX

Yahoo Finance 1mo ago

MIMRYLO Approval Triggered $275M Payments for Protagonist (PTGX). Are Royalties the Better Commercial Model?

General T2PTGX

Investing.com 1mo ago

BMO raises Protagonist Therapeutics price target on Mimrylo approval

General T3PTGX

Seeking Alpha News 1mo ago

Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of Mimrylo for Erythrocytosis in Polycythemia Vera Transcript

General T2PTGX

Investing.com 1mo ago

Protagonist Therapeutics stock rating maintained at Buy by Clear Street

General T3PTGX

Investing.com 1mo ago

Jefferies reiterates Protagonist Therapeutics stock rating on Mimrylo label strength

General T3JEF PTGX

Seeking Alpha News 1mo ago

Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of Mimrylo for Erythrocytosis in Polycythemia Vera - Slideshow

General T2PTGX

Investing.com 1mo ago

Protagonist Therapeutics receives FDA approval for polycythemia vera drug

General T3PTGX

Investing.com 2mo ago

Protagonist Therapeutics CEO Dinesh Patel sells $14.9m in stock

General T3PTGX

Seeking Alpha News 2mo ago

Protagonist Therapeutics: 'Strong Buy' ICOTYDE FDA Approval And PN-881 Advancement

General T2PTGX

Investing.com 3mo ago

Truist raises Protagonist Therapeutics stock price target on Icotyde outlook

General T3PTGX TFC

Yahoo Finance 3mo ago

Why Wall Street’s Wrong for Loving Protagonist Therapeutics Stock

General T2PTGX

Seeking Alpha News 4mo ago

Protagonist Therapeutics: A Royalty-Driven Biotech With Two Shots On Goal

General T2PTGX

Investing.com 4mo ago

Form 144 PROTAGONIST THERAPEUTICS For: 10 June

General T3PTGX

Seeking Alpha News 4mo ago

Protagonist Therapeutics, Inc. (PTGX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

General T2PTGX

Investing.com 4mo ago

Protagonist Therapeutics stock hits all-time high at 107.86 USD

General T3PTGX

Investing.com 4mo ago

Protagonist Therapeutics director Waddill sells $896,760 in common stock

General T3PTGX

Investing.com 5mo ago

Protagonist Therapeutics CEO Dinesh V. Patel sells $7.5m after option exercise

General T3PTGX

Investing.com 5mo ago

Protagonist Therapeutics CEO Dinesh V. Patel sells $7.5m in shares

General T3PTGX

Investing.com 5mo ago

Protagonist Therapeutics director Giraudo sells $5.9m in shares

General T3PTGX

Investing.com 5mo ago

Form 144 PROTAGONIST THERAPEUTICS For: 7 May

General T3PTGX

PTGX news alerts

Get an alert by email or push when a new headline mentions PTGX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.